NCT03740295View on ClinicalTrials.gov

Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 5, 2018

Primary Completion Date

January 5, 2019

Study Completion Date

February 5, 2019

Conditions
Multiple Sclerosis
Interventions
DIETARY_SUPPLEMENT

Coconut oil and epigallocatechin gallate

600 mg of epigallocatechin gallate (EGCG) and 60 ml of coconut oil (3600 mg of TGCM) per day, divided into two doses (one in the morning and one at noon)

OTHER

Placebo

Lactose

Trial Locations (1)

46007

José Enrique de la Rubia Ortí, Valencia

All Listed Sponsors
collaborator

Valencian Institute of Neurorehabilitation Foundation

UNKNOWN

lead

Fundación Universidad Católica de Valencia San Vicente Mártir

OTHER

NCT03740295 - Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis | Biotech Hunter | Biotech Hunter